
Takara Bio is a global biotechnology company that develops reagents, kits, instruments, and services for life science research. The company has strong expertise in molecular biology, genomics, gene delivery, genome editing, stem cell research, and cell and gene therapy.
Its product portfolio supports both routine laboratory workflows and advanced applications. Researchers use Takara Bio products for PCR, cloning, gene expression analysis, next-generation sequencing, single-cell analysis, recombinant protein production, and cell engineering.
PCR reagents are among Takara Bio’s best-known products. The company offers DNA polymerases, PCR master mixes, hot-start enzymes, high-fidelity enzymes, long-range PCR systems, and real-time PCR reagents.
The PrimeSTAR® family is designed for high-fidelity DNA amplification. PrimeSTAR Max DNA Polymerase supports fast PCR setup, while PrimeSTAR GXL DNA Polymerase is suitable for long templates, GC-rich regions, and difficult amplification targets.
Takara Ex Taq®, LA Taq®, and EmeraldAmp® products support routine PCR, genotyping, cloning, mutation analysis, and sequencing preparation. TB Green® and Probe qPCR master mixes are available for quantitative gene expression and nucleic acid detection workflows.
Takara Bio supplies reverse transcriptases and cDNA synthesis kits for standard and challenging RNA samples. PrimeScript™ reverse transcriptase is widely used for first-strand cDNA synthesis, RT-PCR, and real-time RT-PCR.
One-step and two-step RT-qPCR kits are available for gene expression studies, viral RNA research, microRNA analysis, and transcript quantification. These products support low-copy targets and RNA templates with complex secondary structures.
The Mir-X™ product family provides solutions for microRNA cDNA synthesis and qPCR analysis. Researchers can use these reagents in cancer research, biomarker discovery, developmental biology, and disease-related gene expression studies.
In-Fusion® Cloning is one of Takara Bio’s leading molecular biology technologies. It enables seamless and directional cloning without adding unwanted bases to the final construct.
The system supports single-fragment cloning, multiple-fragment assembly, site-directed mutagenesis, and vector modification. It can also simplify the construction of expression vectors, reporter plasmids, viral vectors, and CRISPR-related constructs.
Takara Bio also provides competent cells, cloning vectors, ligation reagents, restriction enzymes, DNA-modifying enzymes, and plasmid purification products. Together, these products support complete workflows from DNA amplification to recombinant construct validation.
Takara Bio offers NGS library preparation solutions for DNA sequencing, RNA sequencing, single-cell sequencing, spatial biology, and low-input sample analysis.
SMART-Seq® technology is a major strength of the company’s sequencing portfolio. It supports full-length cDNA synthesis and transcriptome analysis from single cells or very small amounts of RNA. SMART-Seq products are widely used in single-cell biology, cancer research, neuroscience, immunology, and developmental research.
ThruPLEX® library preparation kits support sequencing from fragmented DNA, cell-free DNA, FFPE DNA, and other limited samples. SMARTer® and PicoPLEX® technologies provide additional options for transcriptomics, whole-genome amplification, and specialized sequencing applications.
Takara Bio develops tools for studying gene expression at single-cell resolution. Its single-cell solutions cover cell isolation, cDNA synthesis, RNA sequencing library preparation, and automated sample processing.
SMART-Seq workflows help researchers detect transcripts, splice variants, and sequence variations across individual cells. These capabilities are useful for identifying rare cell populations and studying cellular heterogeneity.
The company has also expanded into spatial transcriptomics. These technologies allow researchers to examine gene expression while retaining information about the location of cells within tissue samples.
Takara Bio provides products for introducing genetic material into mammalian and other cell types. Its portfolio includes lentiviral, retroviral, and adeno-associated virus systems, as well as transfection reagents and gene expression vectors.
RetroNectin® is used to improve retroviral and lentiviral gene transfer into selected cells. It is especially relevant to T-cell engineering, hematopoietic cell research, and cell therapy development.
Guide-it™ products support CRISPR genome editing experiments. They cover guide RNA design, Cas9 delivery, mutation detection, editing-efficiency analysis, and isolation of edited cell populations.
Tet-On® inducible expression systems allow researchers to control gene expression using tetracycline-responsive technology. These systems are useful when continuous expression may affect cell viability or experimental results.
The Cellartis® portfolio includes human induced pluripotent stem cells, embryonic stem cell products, culture media, differentiation systems, and stem cell-derived cells.
These products support pluripotent stem cell maintenance and differentiation into hepatocytes, cardiomyocytes, pancreatic cells, and other specialized cell types. Researchers use them in disease modeling, drug screening, toxicity testing, developmental biology, and regenerative medicine.
Takara Bio also offers culture systems designed to maintain stable stem cell growth and reproducible differentiation. This makes the Cellartis portfolio suitable for both academic research and pharmaceutical development.
Takara Bio supplies products for recombinant protein expression, purification, labeling, and detection. The portfolio includes bacterial and mammalian expression systems, fluorescent proteins, affinity purification products, and western blot reagents.
Living Colors® fluorescent proteins support the visualization of gene expression, protein localization, and cellular processes. The pCold™ expression system is designed for recombinant protein production at low temperatures in bacterial cells.
These technologies are used in protein function studies, cell imaging, molecular interaction research, and recombinant protein development.
Takara Bio combines gene delivery, cell culture, genome editing, stem cell, and analytical technologies for cell and gene therapy research.
Its products support vector construction, viral vector production, immune-cell modification, gene transfer, cell expansion, and research-scale process development. RetroNectin and viral vector systems are particularly relevant to CAR-T cell research and other genetically modified cell workflows.
The company also provides custom and contract services for gene analysis, cell processing, viral vector development, and biopharmaceutical research.
Takara Bio products are used in genomics, transcriptomics, cancer research, immunology, neuroscience, infectious disease research, developmental biology, stem cell research, and drug discovery.
The brand is especially strong in high-fidelity PCR, seamless cloning, reverse transcription, single-cell RNA sequencing, low-input NGS library preparation, gene delivery, genome editing, and pluripotent stem cell applications.
This broad portfolio allows researchers to connect DNA and RNA preparation, amplification, cloning, sequencing, cell engineering, and functional analysis within an integrated experimental workflow.
Official website link: